Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides safer pharmaceutical product testing, with greater reliability and convenience for a product release to market in total confidence.
Merck’s expertise in sterility testing goes back more than 40 years since the invention of the original Steritest™ closed filtration system. This new fourth-generation unit marks the latest evolution with the Steritest™ NEO device which, along with improved ergonomics, includes the following benefits:
These improvements enhance the user experience with no change in the materials that come into contact with the tested fluid or in performance specification. The membrane and canisters undergo stringent integrity and microbiological tests. These closed Steritest™ NEO devices are supplied with certificates of quality, with data gained from rigorous in-process and release testing to ensure peace of mind.
